Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S5 from Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial
  1. Home
  2. Publications
  3. Supplementary Table S5 from Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial

Supplementary Table S5 from Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial

Authors:
  • AEAnneke L. Eerkens
    Anneke L. Eerkens
  • MEMartha D. Esajas
    Martha D. Esajas
  • KBKoen Brummel
    Koen Brummel
  • AVAnnegé Vledder
    Annegé Vledder
  • NRNienke van Rooij
    Nienke van Rooij
  • APAnnechien Plat
    Annechien Plat
  • SHStefany B. Avalos Haro
    Stefany B. Avalos Haro
  • SPSterre T. Paijens
    Sterre T. Paijens
  • LSLorian Slagter-Menkema
    Lorian Slagter-Menkema
  • Ed Schuuring
    Ed Schuuring
  • NWNaomi Werner
    Naomi Werner
  • JKJos G.W. Kosterink
    Jos G.W. Kosterink

Open Access
Publisher website
Google Scholar
  • 17 March 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.28606312
Abstract
Supplementary Table S5. CD19+ immune infiltration.
Keywords
  • CANCER PREVENTION
  • PRE-NEOPLASIA
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • GYNECOLOGICAL CANCERS
  • CERVICAL CANCER
  • IMMUNOLOGY
  • IMMUNOMODULATION
  • IMMUNOTHERAPY
  • CANCER VACCINES
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.